JENNY BELITZ: Open Payments
NPI 1427062538 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 95 payments from 22 companies in 2025. Trend: 2023 $1,301 · 2024 $1,036 · 2025 $1,396
Food & beverage: $1,353Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $265 |
| Novo Nordisk Inc | 12 | $182 |
| Lilly USA, LLC | 13 | $142 |
| PFIZER INC. | 12 | $138 |
| Amgen Inc. | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Mannkind Corporation | 2 | $65 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
Products named: VRAYLAR, REXULTI, EVENITY, Wegovy, MOUNJARO, CAPLYTA, Ozempic, NURTEC ODT.
Industry payments across NE — which companies pay providers there.
